Ranitidine in acute high-dose organophosphate exposure in rats: Effect of the time-point of administration and comparison with pyridostigmine

Basic and Clinical Pharmacology and Toxicology

Volumn 99, Issue 4, 2006, Pages 312-316

  Petroianu, Georg A ^a   Hasan, Mohamed Y ^a   Nurulain, Syed M ^a   Shafiullah, Mohamed ^a   Sheen, Rajan ^a   Nagelkerke, Nicolas ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMATE ESTERASE INHIBITOR; ORGANOPHOSPHATE; ORGANOPHOSPHATE ESTERASE INHIBITOR; PARAOXON; PYRIDOSTIGMINE; RANITIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINESTERASE INHIBITION; COMPUTER PROGRAM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG POTENCY; HISTAMINE RELEASE; IN VITRO STUDY; INHIBITION KINETICS; INTOXICATION; KAPLAN MEIER METHOD; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ERYTHROCYTES; ORGANOPHOSPHORUS COMPOUNDS; PROSPECTIVE STUDIES; PYRIDOSTIGMINE BROMIDE; RANITIDINE; RATS; TIME FACTORS;

EID: 33750051956     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_215.x     Document Type: Article

References (28)

1. Bajgar, J.: Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004, 38, 151-216.
2. Bartling, A., H. Thiermann, L. Szinicz & F. Worek: Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro. J. Appl. Toxicol. 2005, 25, 568-571.
3. Buckley, N., M. Eddleston & L. Szinicz: Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev 2005, 1, CD005085.
4. Dart, R. C., L. R. Goldfrank, P. A. Chyka, D. Lotzer, A. D. Woolf, J. McNally, W. R. Snodgrass, K. R. Olson, E. Scharman, R. J. Geller, D. Spyker, M. Kraft & R. Lipsy: Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann. Emerg. Med. 2000, 36, 126-132.
5. Dunn, M. A., B. E. Hackley & F. R. Sidell: Pretreatment for nerve agent exposure. In: Textbook of military medicine: Medical aspects of chemical & biological warfare. Eds.: F. R. Sidell, E. T. Takafuji & D. R. Franz. Borden Institute, Walter Reed Army Medical Center, Washington, DC, 1997, pp. 181-196.
6. Eddleston, M., L. Szinicz, P. Eyer & N. Buckley: Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Quart. J. Med. 2002, 95, 275-283.
7. Grant, S. M., H. D. Langtry & R. N. Brogden: Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 1989, 37, 801-870.
8. Gwee, M. C. E. & L. S. Cheah: Antimuscarinic and anticholinesterase activity of cimetidine and ranitidine: clinically significant?. Brit. J. Clin. Pharmacol. 1991, 32, 260-261.
9. Hansen, W. E. & S. Bertl: Inhibition of cholinesterases by ranitidine. Lancet 1983a, 29, 235.
10. Hansen, W. E. & S. Bertl: Inhibition of acetylcholinesterases - a relevant side effect of ranitidine? Z. Gastroenterol. 1983b, 21, 164-167.
11. Johnson, M. K., D. Jacobsen, T. J. Meredith, P. Eyer, A. J. Heath, D. A. Ligtenstein, T. C. Marrs, L. Szinicz, J. A. Vale & J. A. Haines: Evaluation of antidotes for poisoning by organophosphourus pesticides. Emerg. Med. 2000, 12, 22-37.
12. Kounenis, G., M. Koutsoviti-Papadopoulou & V. Elezoglou: Ketamine inhibits the anticholinesterase activity of ranitidine and physostigmine. Gen. Pharmacol. 1994, 25, 631-634.
13. Laine-Cessac, P., A. Turcant, A. Premel-Cabic, J. Boyer & P. Allain: Inhibition of cholinesterases by histamine 2 receptor antagonist drugs. Res. Commun. Chem. Pathol. Pharmacol. 1993, 79, 185-193.
14. Levine, R.: Recognized and possible effects of pesticides in humans. In: Handbook of pesticide toxiclogy, General principles, Vol. 1. Eds.: W. J. Hayes & E. R. Laws. Academic Press, San Diego 1991, pp. 275-360.
15. Louis, W. J., G. W. Mihaly, R. G. Hanson, A. Anderson, J. J. McNeil, N. D. Yeomans & R. A. Smallwood: Pharmacokinetic and gastric secretory studies of ranitidine in man. Scand. J. Gastroenterol. 1981, 69 Suppl., 11-17.
16. Marino, M. T., B. G. Schuster, R. P. Brueckner, E. Lin, A. Kaminskis & K. C. Lasseter: Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J. Clin. Pharmacol. 1998, 38, 227-235.
17. Namba, T.: Cholinesterase inhibition by organophospourus compounds, and its clinical effects. Bull. WHO 1971, 44, 289-307.
18. Namba, T., C. T. Nolte, J. Jackrel & D. Grob: Poisoning due to organophosphate insecticides: acute and chronic manifestations. Amer. J. Med. 1971, 50, 457-492.
19. Peter, J. V. & A. M. Cherian: Organic insecticides. Anaesth. Intensive Care 2000, 28, 11-21.
20. Peter, J. V., J. L. Moran & P. Graham: Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit. Care Med. 2006, 34, 502-510.
21. Petroianu, G., L. M. Toomes, A. Petroianu, W. Bergeler & R. Rüfer: Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini pigs. J. Appl. Toxicol. 1998, 18, 293-298.
22. Petroianu, G. A., F. Hardt, L. M. Toomes, W. Bergler & R. Ruefer: High-dose intravenous paraoxon exposure does not cause organophosphate-induced delayed neuropathy (OPIDN) in mini pigs. J. Appl. Toxicol. 2001, 21, 263-268.
23. Petroianu, G. A., A. Missler, K. Zuleger, C. Thyes, V. Ewald & W. H. Maleck: Enzyme reactivator treatment in organophosphate exposure: The clinical relevance of thiocholine-esteratic activity of pralidoxime. J. Appl. Toxicol. 2004, 24, 429-435.
24. Petroianu, G.: Organophosphate poisoning: the lesser-known face of atoxidrome. (letter). Eur. J. Emerg. Med. 2005a, 12, 102-103.
25. Petroianu, G. A., K. Arafat, A. Schmitt & M. Y. Hasan: Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effects of ranitidine. J. Appl. Toxicol. 2005b, 25, 60-67.
26. Petroianu, G. A., M. Y. Hasan, S. M. Nurulain, K. Arafat, M. Shafiullah & O. Naseer: Protective agents in acute high dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats. J. Appl. Toxicol. 2005c, 25, 68-73.
27. Thompson, C. M. & R. J. Richardson: Anticholinesterase insecticides. In: Pesticide toxicology and international regulation (Current toxicology series). Eds.: T. C. Marrs & B. Ballantyne. John Wiley & Sons Ltd., Chichester 2004, 89-127.
28. Zoch, E.: Die Wirkung organischer Phosphorsäureester bzw. Phosphorsäureester auf verschiedene Enzyme. Arzneimittelforschung 1971, 21, 181-187.